Southwest Journal of Pulmonary and Critical Care (Oct 2021)

Utility of Endobronchial Valves in a Patient with Bronchopleural Fistula in the Setting of COVID-19 Infection: A Case Report and Brief Review

  • Nazanin Sheikhan MD,
  • Elizabeth J. Benge MD,
  • Amanpreet Kaur MD1,
  • Jerome K Hruska DO,
  • Yi McWhorter DO,
  • Arnold Chung MD

DOI
https://doi.org/10.13175/swjpcc046-21
Journal volume & issue
Vol. 23, no. 4
pp. 109 – 114

Abstract

Read online

Patients with COVID-19 pneumonia frequently develop acute respiratory distress syndrome (ARDS), and in severe cases, require invasive mechanical ventilation. One complication that can develop in patients with ARDS who are mechanically ventilated is a bronchopleural fistula (BPF). Although rare, the frequency of BPF in patients with COVID-19 pneumonia is increasingly recognized. Here, we present a 48-year old man with BPF associated with COVID-19 pneumonia. Treatment with a commercial endobronchial valve (EBV) system resulted in reduced air leak allowing for tracheostomy placement. Our case adds to a growing body of evidence suggesting that the presence of COVID-19 pneumonia does not hinder the utility of EBV’s in the treatment of BPF’s.

Keywords